Anti-virulence compositions and methods

US10227282B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10227282-B2
Application numberUS-201414445713-A
CountryUS
Kind codeB2
Filing dateJul 29, 2014
Priority dateMar 8, 2010
Publication dateMar 12, 2019
Grant dateMar 12, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of reducing the virulence of a bacterium that expresses accessory gene regulator A (AgrA) includes administering to the bacterium an amount of AgrA antagonist effective to inhibit the synthesis of one or more virulence factors by the bacterium.

First claim

Opening claim text (preview).

Having described the invention, the following is claimed: 1. A pharmaceutical composition comprising an accessory gene regulator A (AgrA) antagonist having the formula: and pharmaceutically acceptable salts thereof, and an antibiotic. 2. A pharmaceutical composition comprising an accessory gene regulator A (AgrA) antagonist having the formula: wherein R 1 and R 2 are each independently selected from the group consisting of H, hydroxy, carboxy, lower alkoxy, lower alkoxyhydroxy, lower alkyl, alkenyl, sulfonic, and halo; R 3 is a C2-C6 lower alkyl; and pharmaceutically acceptable salts thereof, and an antibiotic.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Adaptation or attenuation of cells · CPC title

  • for joint disorders, e.g. arthritis, arthrosis · CPC title

  • C07C49/83Primary

    polycyclic · CPC title

  • A61K31/12Primary

    Ketones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10227282B2 cover?
A method of reducing the virulence of a bacterium that expresses accessory gene regulator A (AgrA) includes administering to the bacterium an amount of AgrA antagonist effective to inhibit the synthesis of one or more virulence factors by the bacterium.
Who is the assignee on this patent?
Univ Case Western Reserve
What technology area does this patent fall under?
Primary CPC classification C07C49/83. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).